Avricore Health (AVCRF) 6-K Interim Financial Statements

_{Exhibit 99.6}

May 17, 2016

VIA SEDAR

TO:

BC Securities Commission

Alberta Securities Commission

TSX Venture Exchange

Dear Sirs/Mesdames:

Re:

VANC Pharmaceuticals Inc. (the “Company”) – Notice of Change of Auditor

Under National Instrument 51-102, we advise that the Company’s auditor,Smythe LLP,Chartered Accountants (the “former auditor”), has resigned and that the Company appointedAdam Sung Kim Ltd., Chartered Professional Accountant (the “successor auditor”), effectiveMay 17, 2016.

Please find enclosed the following:

1.

Notice of Change of Auditor datedMay 12, 2016 (the “Notice”), a copy of which has been delivered to each of the former and successor auditor;

2.

Letter from the former auditor datedMay 12, 2016, a copy of which has been delivered to the successor auditor; and

3.

Letter from the successor auditor datedMay 12, 2016, a copy of which has been delivered to the former auditor.

We confirm that the Company’s Board of Directors has reviewed the Notice, the letter from the former auditor, and the letter from the successor auditor.

Yours truly,

VANC PHARMACEUTICALS INC.

SIGNED:  “Eugene Beukman”

Eugene Beukman

Director